- Home
- RELI vs VRPX Comparison
RELI vs VRPX Comparison
Compare RELI & VRPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RELI
- VRPX
- Stock Information
- Founded
- RELI 2013
- VRPX 2016
- Country
- RELI United States
- VRPX United States
- Employees
- RELI N/A
- VRPX N/A
- Industry
- RELI Specialty Insurers
- VRPX Medicinal Chemicals and Botanical Products
- Sector
- RELI Finance
- VRPX Health Care
- Exchange
- RELI Nasdaq
- VRPX Nasdaq
- Market Cap
- RELI 3.4M
- VRPX 3.6M
- IPO Year
- RELI N/A
- VRPX 2021
- Fundamental
- Price
- RELI $1.24
- VRPX $1.22
- Analyst Decision
- RELI Strong Buy
- VRPX Hold
- Analyst Count
- RELI 1
- VRPX 1
- Target Price
- RELI $119.00
- VRPX N/A
- AVG Volume (30 Days)
- RELI 31.3K
- VRPX 444.2K
- Earning Date
- RELI 03-06-2025
- VRPX 05-12-2025
- Dividend Yield
- RELI N/A
- VRPX N/A
- EPS Growth
- RELI N/A
- VRPX N/A
- EPS
- RELI N/A
- VRPX N/A
- Revenue
- RELI $14,054,361.00
- VRPX N/A
- Revenue This Year
- RELI N/A
- VRPX N/A
- Revenue Next Year
- RELI N/A
- VRPX N/A
- P/E Ratio
- RELI N/A
- VRPX N/A
- Revenue Growth
- RELI 2.35
- VRPX N/A
- 52 Week Low
- RELI $1.13
- VRPX $1.08
- 52 Week High
- RELI $18.53
- VRPX $105.98
- Technical
- Relative Strength Index (RSI)
- RELI 36.10
- VRPX 15.84
- Support Level
- RELI $1.13
- VRPX $1.08
- Resistance Level
- RELI $1.37
- VRPX $3.77
- Average True Range (ATR)
- RELI 0.07
- VRPX 0.41
- MACD
- RELI 0.01
- VRPX -0.05
- Stochastic Oscillator
- RELI 40.74
- VRPX 4.16
About RELI Reliance Global Group Inc.
Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing an acquisition strategy, initially and primarily focused on wholesale and retail insurance agencies. Its primary strategy is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.
About VRPX Virpax Pharmaceuticals Inc.
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.